effect of post surgery platelet rich plasma on osteochondral lesions of talus

Evaluation of the effect of platelet rich plasma on outcomes after arthroscopic microfracture surgery in osteochondral lesions of talus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230227057547N1

Enrollment

Registered

2023-05-12

Start date

2020-03-20

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteochondral lesion of the talus. Osteochondropathy, unspecified

Interventions

Intervention 1: Intervention group: after surgery the patient receives two injections of PRP. Intervention 2: Control group: only undergo surgery/ no placebo given/ no prp injection recieved.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients undergoing arthroscopic surgery for osteochondral talus lesions patients older than 18 years

Exclusion criteria

Exclusion criteria: patients who did not consent patients with previous ankle surgery patients with previous ankle fracture patients with foot deformities patients using other treatments (graft etc) coagulopathy patients patients using anticoagulants patients who left the study or did not continue

Design outcomes

Primary

Measure	Time frame
AOFAS score. Timepoint: 12 months after injection. Method of measurement: history and physical examination.;VAS (Visual Analog Scale) score. Timepoint: 12 months after injection. Method of measurement: history and physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Sabaghzadeh Irani

Shahid Beheshti University of Medical Sciences

masaro1982@yahoo.com+98 21 25719

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026